课题基金 / 基金详情

The trial of treatment in choroidal neovascularization by the drug release system of NK4,inhibitors of hepatocyte growth factor

The trial of treatment in choroidal neovascularization by the drug release system of NK4,inhibitors of hepatocyte growth factor
NK4、肝细胞生长因子抑制剂药物释放系统治疗脉络膜新生血管的试验
批准号:
14571682
负责人:
OKUDA Masatoshi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
肝细胞生长因子(HGE)对人脐静脉内皮细胞(HUVEC)具有与血管内皮生长因子(VEGF)或碱性成纤维细胞生长因子(BFGF)同样的促生长作用。有证据表明,HGF的拮抗剂NK4可以抑制血管内皮生长因子和碱性成纤维细胞生长因子诱导的新生血管形成。(1)检测NK4对人脐静脉内皮细胞和人视网膜色素上皮细胞(ARPE-19)的增殖抑制作用。在96个孔板上,每个孔散布1×10^3个细胞。将其置于浓度为5,10,50,100,500 nm的NK4中72小时。我们用XTT法评价其对细胞增殖的抑制作用。NK4,50 NM以上,与人脐静脉内皮细胞对照。另一方面,任何浓度的NK4都不影响ARPE-19。因此,NK4的细胞增殖抑制作用是对血管内皮细胞的特异性作用,仅抑制新生血管而不影响其周围细胞。(2)评价NK4对实验性脉络膜新生血管的抑制作用。用激光光凝法诱导大鼠实验性新生血管形成,玻璃体腔内注射溶于牛血清白蛋白的5μL液(10μM)。对照组玻璃体腔内注射BSS 5ml。光凝后2周行荧光素血管造影,观察新生血管的形成情况。光镜下测量新生血管厚度。与对照组相比,差异不是决定性的。
英文摘要
Hepatocyte growth factor (HGE) is shown growth promoting action as much as VEGF (vascular endothelial growth factor) or bFGF (basic fibroblast growth factor) to the human umbilical vein endothelial cells (HUVEC). It is becoming clear that NK4,which is the antagonist of the HGF, inhibits the neovascularization was induced VEGF and bFGF.(1)We evaluated the proliferating suppression effect of NK4 to the HUVEC and the human retinal pigment epithelial cell (ARPE-19). On the 96 well plates, each hole was scattered 1x10^3 each cells. It was made to expose for 72 hours to the NK4 of the concentration of 5,10,50,100,500 nM. We evaluated the cellular proliferating suppression effect by using a XTT assay. NK4,50 nM or more, contrastively controlled to HUVEC. On the other hand, Any concentration of NK4 was not influenced ARPE-19. Therefore, it was suggested that a cellular proliferation suppression effect of NK4 was specific action to vascular endothelial cells and controlled only neovascularization without affecting its surrounding cells.(2)We evaluated the suppression effect of NK4 to the experimental choroidal neovascularization. Experimental CNV was induced in rats by laser photocoagulation, and 5μl (10μM) of NK4,dissolved in BSS, was injected in the vitreous cavity. Controls received a intravitreal injection 5ml of only BSS. We performed fluorescein angiography 2nd weeks after photocoagulation, and we evaluated the formation of CNV. It measured the thickness of the CNV with light microscope. As compared with contrast, the difference was not seen conclusively.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
米糠活性七肽介导HGF调控脂滴自噬改善骨关节炎的机制研究
  • 批准号:
    2025JJ50521
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    邝磊
  • 依托单位:
复方香巴戟膏介导的NO/HGF/c-met通路活化卫星细胞促进损伤后肌肉组织再生
  • 批准号:
    2025JJ70694
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    丁轩
  • 依托单位:
安罗替尼通过调控HGF/c-MET信号通路与自噬相互作用促进人脑胶质瘤细胞凋亡的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    刘细帮
  • 依托单位:
MSC-EVs来源circKCMF1通过调控巨噬细 胞Akt-FOXO3a-HGF轴促进老年肝脏再生 的作用机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    张杰滨
  • 依托单位: